This guide explores practical strategies for extraction-free RPA sample preparation based on recent peer-reviewed research, with a focus on translating those findings into considerations for assay development. It also highlights reagents that can support the development and optimization of extraction-free workflows.
Research HighlightThis guide draws on the workflow development framework from Wilkinson, Barra, and Richards-Kortum (ACS Omega, 2025), which compared chemical, enzymatic, and thermal extraction-free sample preparation strategies for integrating blood and buccal swab samples into an RPA assay for β-globin DNA. Across the sample types and concentrations tested, a one-step alkaline (NaOH) lysis gave the most consistent balance of performance and simplicity.
RPA is well suited to point-of-care molecular diagnostics because it amplifies nucleic acids under isothermal conditions and can tolerate partially processed biological samples better than conventional PCR. That tolerance opens the door to simpler sample preparation. Instead of isolating nucleic acids through column- or magnetic bead-based extraction, an extraction-free workflow uses minimal processing to release the target directly from the sample before amplification.
At a high level, the workflow consists of four steps:
The concept is simple. Making it reliable requires more optimization. Skipping extraction means the lysate may retain proteins, nucleases, cellular debris, and other components normally removed during that step. Extraction-free assay development therefore becomes a balancing act: release enough target for sensitive detection without carrying enough inhibitory material into the reaction to interfere with amplification.
When choosing an extraction-free lysis strategy, more processing doesn't necessarily mean better performance.
The study built a panel of candidate workflows from three lysis mechanisms (chemical, enzymatic with proteinase K, and heat) used alone or in combination, against a water-only no-lysis control. Two design choices shape how the results read:
The panels differed by matrix. Proteinase K was also always paired with GuHCl and heat rather than tested on its own, so these results describe combined workflows rather than the enzyme in isolation.
Across both buccal swabs and blood, one-step NaOH lysis provided the strongest balance of amplification performance, speed, and workflow simplicity. For both matrices, the NaOH workflow:
Proteinase K–based workflows showed a different tradeoff: more processing, less consistency. For buccal swabs, the one-step GuHCl/proteinase K/heat workflow produced no detectable amplification at all. The two-step version did amplify, but with more variable time-to-detection results and roughly 25 minutes of sample preparation versus about 10 for NaOH. The gap widened as samples were diluted. The proteinase K workflow lost signal at 5% and 1% buccal dilution while NaOH-based methods kept amplifying, and in blood it amplified four of six replicates against consistent amplification across all NaOH conditions.
Heat alone was evaluated for blood samples. It amplified all replicates but with greater variability in time to detection than the NaOH workflows, which is why it wasn't carried forward.
This isn't an argument against non-chemical lysis, but rather an argument for tailoring the lysis mechanism to the specific sample matrix and downstream assay requirements. In this study, simple alkaline lysis gave the best combination of performance and simplicity for blood and buccal swabs. Proteinase K–based approaches remain worth evaluating when protein content or other matrix characteristics create barriers that alkaline lysis alone may not adequately address.
The table below widens the view, comparing these approaches alongside strategies not directly tested in this study but relevant to RPA workflow design.
| Sample Preparation Strategy | Advantages | Considerations | Typical Applications |
|---|---|---|---|
| Alkaline lysis (e.g., NaOH) | Minimal reagents, fastest processing, simplest workflow | Final reagent concentration must stay within RPA's tolerance window | Point-of-care diagnostics and field testing |
| Enzymatic digestion (proteinase K) | Digests proteins, inactivates endogenous nucleases, can improve access to nucleic acid in protein-rich matrices | Typically paired with a chaotropic agent and/or heat; requires incubation and a downstream inactivation step; added complexity may not pay off in every matrix | Protein-rich or complex biological matrices where alkaline lysis alone is insufficient |
| Heat-assisted lysis | Simple, no specialized reagents | Amplified reliably in blood but with greater variability in time to detection; more reliable as a supplement to chemical lysis or as an enzyme-inactivation step | Supplemental lysis or enzyme inactivation |
| Hybrid workflows | Can combine mechanisms for difficult samples | Higher process complexity, longer time to result | Challenging sample types or custom assays where simpler methods have been tried and fall short |
| Sample Matrix | Common Challenges | Design Considerations |
|---|---|---|
| Whole blood | Hemoglobin, plasma proteins, endogenous nucleases | RPA tolerated up to 0.1 µL of blood per reaction in this study — minimize inhibitor carryover while keeping enough target |
| Buccal swabs | Variable cellular recovery, cellular debris | RPA tolerated up to 1 µL of swab sample per reaction — optimize lysis efficiency while keeping the workflow simple |
A practical development workflow can be organized around six steps:
Extraction-free RPA development is ultimately an exercise in balancing these variables rather than maximizing any one of them. The strongest workflow is the one that releases sufficient target, controls inhibitors, supports reliable amplification, and remains practical for the environment in which the assay will be used.
Moving from an extraction-free RPA concept to a robust assay requires the right combination of sample preparation and amplification reagents. To support that process, we've put together a set of tools for developing and optimizing RPA workflows across different sample types and assay requirements.
For sample preparation, Proteinase K and DNase I help clear the way for reliable amplification, while our RPA & RT-RPA Kits provide the amplification chemistry itself. If you're working with Proteinase K, the Proteinase K User Guide is a useful technical resource to have on hand.
If you're developing an assay for a specific application or scale, contact our team to discuss OEM packaging, bulk enzyme supply, and assay development support.
Visit our RPA Resource Hub for additional RPA guidance, including assay optimization guides, CRISPR diagnostic integration, and primer design.
Not necessarily. RPA can amplify DNA directly from crude sample lysates, making extraction-free workflows possible for some sample types. Successful direct amplification depends on releasing enough target DNA while keeping sample-derived inhibitors and lysis reagents within concentrations the RPA reaction can tolerate.
There isn't one lysis method that works best for every sample type. In the study highlighted here, one-step alkaline (NaOH) lysis provided the best combination of consistency, speed, and workflow simplicity for blood and buccal swab samples. Other matrices may benefit from enzymatic, thermal, or hybrid approaches, so lysis should be optimized alongside the downstream RPA reaction.
Yes. Proteinase K can support sample preparation by digesting proteins and inactivating endogenous nucleases, particularly in protein-rich or complex matrices. Because active proteinase K can also degrade proteins required for RPA, the workflow should include an appropriate inactivation step before amplification.
The amount depends on the sample matrix and how the sample is processed. In the study highlighted here, a 50 µL RPA reaction tolerated raw-matrix equivalents of approximately 1 µL of undiluted buccal swab sample or 0.1 µL of whole blood before inhibition affected amplification.
This doesn't necessarily mean pipetting those volumes directly into the RPA reaction. Samples can first be diluted during lysis, allowing a larger, practical volume of processed lysate to be added while keeping the effective amount of raw sample within the reaction's tolerance range. In this study, 10 µL of diluted lysate was added to the RPA reaction.
Extraction-free RPA has been demonstrated with a range of biological samples, including blood and buccal or saliva-derived samples. The appropriate sample preparation strategy depends on the matrix, since different sample types introduce different inhibitors and amounts of cellular material. Each matrix should therefore be evaluated for target release, inhibitor tolerance, and the amount of crude lysate that can be carried into the RPA reaction.
Cart
Account
Your Orders
Sign Out
Sign In